Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-016700)

Filing Details

Accession Number:: 0000899243-20-016700
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-06-16 19:09:01
Reporting Period:: 2020-06-12

Accepted Time:: 2020-06-16 19:09:01
Original Submission Date:: 2020-06-16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576263	Mirati Therapeutics Inc.	MRTX	Pharmaceutical Preparations (2834)	462693615

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1642355	Ltd. Braslyn	Cay House, Ep Taylor Drive Lyford Cay, New Providence C5 N7776		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-06-12	600,000	$97.00	2,535,966	No	4	S	Direct
Common Stock	Acquisiton	2020-06-12	600,006	$0.00	3,135,972	No	4	M	Direct
Common Stock	Disposition	2020-06-12	6	$100.69	3,135,966	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to purchase)	Disposition	2020-06-12	600,006	$5.60	600,006	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,990,420	2017-01-06		No	4	M	Direct

Footnotes

The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 9.99% of the issuer's common stock.